Aelis Farma SA (AELIS.PA) Stock Price

€1.3 0%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    9

  • Fundamental

    1

  • Technical

    3

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Aelis Farma SA, AI stock picks, stock alerts and much more.

Sign up

AELIS.PA AI Stock Analysis

AI stock analysis for AELIS.PA is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Aelis Farma SA (AELIS.PA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Aelis Farma SA (AELIS.PA) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Aelis Farma SA (AELIS.PA), currently trading at €1.3, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About AELIS.PA

LSE

  • Aelis Farma SA, a biotechnology company, engages in the research and development of treatments for brain diseases.

  • Symbol

    AELIS.PA

  • Market

    EURONEXT

  • Industry

    Biotechnology

  • Market Cap

    17.8M

Similar Stocks

VLA.PA Valneva SE
VLA.PA		 €3.91
22.5%
5
TUB.BR Financière de Tubize SA
TUB.BR		 €161.8
0.8%
8
OSE.PA OSE Immunotherapeutics SA
OSE.PA		 €6.16
2.5%
6
UCB.BR UCB SA
UCB.BR		 €199.1
0.9%
6
IPH.PA Innate Pharma S.A.
IPH.PA		 €1.99
1.2%
5

News

No news articles.

AELIS.PA Alternative Data

Web Traffic

Aelis Farma SA receives an estimated 1432 monthly visitors to aelisfarma.com.

  • Web Traffic

    1432

  • Change from Previous Month

    226.9%

  • 3 Month Change

    230.7%

  • YoY Change

    230.7%

Twitter Followers

Aelis Farma SA has 119 Twitter Followers on its main Twitter (also known as X) account, which is up by 1.7% over the last month.

  • Twitter Followers

    119

  • Daily Change

    0.8%

  • 1 Month Change

    1.7%

  • 3 Month Change

    5.3%

LinkedIn Followers

4,784 are following Aelis Farma SA on LinkedIn, up by 1% over the last month.

  • LinkedIn Followers

    4784

  • Daily Change

    1%

  • 1 Month Change

    1%

  • 3 Month Change

    5.3%

LinkedIn Employees

According to LinkedIn, Aelis Farma SA has 29 employees.

  • LinkedIn Employees

    29

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    6.5%

News Mentions

Aelis Farma SA was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

Reddit Mentions

Aelis Farma SA has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • 1 Month Change

    0%

  • 3 Month Change

    0%

AELIS.PA Financials

AELIS.PA Key Metrics

  • Total Revenue

    €3.3M

  • Net Income

    -€3.9M

  • Earnings per Share

    -€0.28

  • Free cash flow

    -€3.5M

  • EBITDA

    -€4.5M

  • EBITDA Ratio

    -1.33874

  • Total Assets

    €19.7M

AELIS.PA 2-year Revenue & Income
AELIS.PA 2-year Free Cash Flow

AELIS.PA Technicals

AELIS.PA SMA
AELIS.PA RSI

FAQ

What's the current price of Aelis Farma SA (AELIS.PA) Stock?
The price of an Aelis Farma SA (AELIS.PA) share is €1.3.

What's the market cap of Aelis Farma SA?
The current market cap of Aelis Farma SA is 17.8M.

Should I buy or sell AELIS.PA?
Aelis Farma SA shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Aelis Farma SA is better viewed as a hold or accumulate position while waiting for further developments.

Is Aelis Farma SA a good investment?
The current analysis of Aelis Farma SA's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Aelis Farma SA's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Aelis Farma SA (AELIS.PA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Aelis Farma SA stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Aelis Farma SA (AELIS.PA) that investors often compare it to?
Aelis Farma SA (AELIS.PA) is often compared to similar stocks such as Valneva SE, Financière de Tubize SA, OSE Immunotherapeutics SA, UCB SA and Innate Pharma S.A..

What is the forecast for Aelis Farma SA's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Aelis Farma SA's stock price to be around €1.31 in 2026. Starting from the current price of €1.3, this represents a 0.8% change in price, indicating a neutral outlook for the stock.

How to buy Aelis Farma SA (AELIS.PA) Stock?
Aelis Farma SA stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Aelis Farma SA shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.